• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Rebecca Cobb, MS

Latest:

Dual-Eligible Beneficiaries’ Grocery Supplemental Benefit Use and Health Care Utilization

Medicare Advantage grocery supplemental benefit use is associated with increased outpatient care, suggesting that policy changes allowing for nonmedical supplemental benefits could improve beneficiaries’ health, especially for dual-eligible beneficiaries.


Luyu Xie, PharmD

Latest:

Timely Preterm-Birth Prediction Among Pregnant Women in Medicaid Without Preterm-Birth History

A novel prediction model is developed that accurately predicts preterm birth in a timely manner among pregnant women in Medicaid without preterm-birth history.


Nick Bouchard, PharmD

Latest:

The Future of Oncology Research in a Shifting Policy Landscape

Panelists discuss how evolving policy reforms will reshape oncology research by balancing innovation, access, and affordability.


Navid Sadeghi, MD, MSPH

Latest:

How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care

Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.


Bhavana (Tina) Bhatnagar, DO

Latest:

Precision Medicine Advances Highlight Ongoing Equity Challenges: Tina Bhatnagar, DO

Despite the impact of targeted treatment in oncology, much work remains to bring these therapeutics to all patients, says Bhavana (Tina) Bhatnagar, DO.


Yongkang Zhang, PhD

Latest:

Social Determinants of Health and High-Cost Utilization Among Commercially Insured Population

Residence in a more disadvantaged neighborhood was associated with higher likelihood of being a high-cost utilizer among older adults and lower likelihood among younger adults.


Jordyn Sava

Latest:

FDA Releases Draft Guidance for MDS Drug Development

The FDA's new guidance shapes drug development for myelodysplastic syndromes (MDS), emphasizing trial design, patient selection, and safety reporting for better treatment outcomes.


Swarnali Goswami, MS

Latest:

Impact of Food Affordability on Diabetes-Related Preventable Hospitalization

Medicaid enrollees residing in counties with greater food affordability had lower odds of preventable hospitalization related to diabetes.


Edwin A. Silveira, BS

Latest:

Evaluation of a Pediatric Asthma High-risk Scoring Algorithm

An asthma risk score using 7 clinically relevant parameters evaluated in a pediatric Medicaid managed care population can stratify risk for following-year asthma hospitalization.



Tammy Cody, MSW, LCSW

Latest:

Contingency Management in a Perinatal Substance Exposure Clinic

Project CARA, a perinatal substance exposure clinic, has implemented a contingency management program that targets appointment attendance for patients with any use disorder, regardless of substance or urine drug screen results.


Stephen Chenard, MSc

Latest:

Operating Room Efficiency of Orthopedic Surgery During the COVID-19 Era

The authors analyzed the impacts of COVID-19 on orthopedic operating room efficiency via comparison of 14,856 surgeries performed before, during, and after the pandemic.


Elizabeth A. Luth, PhD

Latest:

Clinician-Identified Health Characteristics and Palliative Care Eligibility: Is Dementia Overlooked?

Clinicians may underassess the need for community-based palliative care among patients with dementia.


Shanyue Zeng, MA | Image Credit: LinkedIn
Shanyue Zeng, MA

Latest:

Contributor: Beyond the Sloganeering—A Data-Driven Analysis of Recent 340B Growth

This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price.


Katie Abouzahr, MD  | Image Credit: © Johnson & Johnson
Katie Abouzahr, MD

Latest:

How Nipocalimab Targets Unmet Needs in Autoimmune Care

In part 4 of our interview, we learn more about nipocalimab’s safety profile and how this investigative agent might address unmet needs for patients with generalized myasthenia gravis.


Oleg Melamed, MD

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.


Ali İnal, MD

Latest:

Evaluation of Biosimilar Trastuzumab MYL-1401O in HER2-Positive Breast Cancer

The authors evaluate the effect and safety of biosimilar trastuzumab MYL-1401O in human epidermal growth factor receptor 2 (HER2)–positive early-stage (neoadjuvant and adjuvant therapy) and metastatic (palliative therapy) breast cancer using real-world data.


Michael Goulet, DO

Latest:

Reflecting on Global Pulmonary Medicine Insights at ATS 2025

Attendees at the American Thoracic Society (ATS) 2025 International Conference highlight global networking, scientific advancements, and professional development at this year's meeting.


Stephen Clarke, BSBA

Latest:

Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy Population

The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.


Ryan Haumschild, PharmD, MS, MBA

Latest:

Unmet Needs and the Future of Desmoid Tumor Management

Experts discuss the unmet needs in desmoid tumor management, emphasizing personalized treatment, quality of life, and the importance of specialized care.


Julie M. Bailey, MBA

Latest:

Telemedicine Catches On: Changes in the Utilization of Telemedicine Services During the COVID-19 Pandemic

This analysis of health insurance claims data demonstrates rapid increase and sustained high utilization of telemedicine services during the COVID-19 pandemic.


Lindsay Grossman, BA

Latest:

An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19

For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.


Karen E. Joynt Maddox, MD, MPH

Latest:

Hospitals’ Strategies to Reduce Costs and Improve Quality: Survey of Hospital Leaders

Hospitals pursue a broad range of efforts to improve quality, with those participating in bundled payments attempting to reduce postacute care to a greater degree than nonparticipants.


Azmat Sidhu, MPH

Latest:

Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities

This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.


Suzanne M. Kinsky, PhD, MPH

Latest:

A Scoping Review of US Insurers’ Use of Patient-Reported Outcomes

This scoping review found 350 articles that discuss US health insurance providers’ use of patient-reported outcomes about health-related quality of life.


Chance Scott

Latest:

Contributor: Providers and Patients Push Back, Payers Push Forward—Co-pay Mitigation Programs

Research shows how commercial health plans impact payer trends in the co-pay landscape and provides key areas that pharmaceutical and biotech manufacturers can explore to ensure patient access.


Elizabeth Medina

Latest:

Patient Experience in a COVID-19 Patient Home Monitoring Program

Patients who participated in a COVID-19 patient home monitoring program were satisfied with their care and stated that their participation made them less likely to seek care in the emergency department.


Natasha Mesinkovska, MD

Latest:

Clinical Considerations in the Treatment of Alopecia Areata

Neil Minkoff; Natasha Mesinkovska, MD; and Brett King, MD, PhD discuss the diagnosis and disease assessment in alopecia areata along with clinical considerations.


Valerie A. Smith, DrPH

Latest:

Predictors of Discharge From the VA Caregiver Support Program

The year of application predicts discharge from the Department of Veterans Affairs (VA) caregiver program. Unexpected, disallowed criteria also predict discharge, with significant others facing higher discharge risk than spouses.


Eytan Stein, MD

Latest:

Final Thoughts on the Future of AML Care

Panelists discuss how AML treatment has entered an exciting era of personalized medicine with increasing oral options and targeted therapies, while identifying immunotherapy as a major unmet need and expressing optimism about patients achieving long-term survival on current regimens.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.